Literature DB >> 3616395

Deposition pattern from a nasal pump spray.

S P Newman, F Morén, S W Clarke.   

Abstract

The initial distribution and subsequent clearance of aerosol from a hand-operated nasal pump spray has been assessed from gamma camera scans in ten normal subjects, following labelling of placebo sprays with 99Tcm labelled Teflon particles (mean diameter 2 micron). Aerosol was concentrated chiefly in the anterior part of the nose, but the area of deposition varied between subjects. No particles reached the lungs. A mean 56% of the dose was retained at the initial site of deposition 30 minutes after administration, while the remaining 44% of the dose had cleared to the nasopharynx. The initial partitioning of nasal pump sprays between ciliated and non-ciliated zones is relevant both for effective topical therapy of the nasal cavity, and for possible systemic drug delivery by the intranasal route.

Mesh:

Substances:

Year:  1987        PMID: 3616395

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  6 in total

1.  Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder.

Authors:  L Thorsson; O Borgâ; S Edsbäcker
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 2.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

Review 3.  Intranasal therapy with opioids for children and adolescents with cancer: results from clinical studies.

Authors:  Silvia Triarico; Michele Antonio Capozza; Stefano Mastrangelo; Giorgio Attinà; Palma Maurizi; Antonio Ruggiero
Journal:  Support Care Cancer       Date:  2019-06-01       Impact factor: 3.603

Review 4.  The Proposed Usage of Intranasal Steroids and Antihistamines for Otitis Media with Effusion.

Authors:  Rachel E Roditi; David S Caradonna; Jennifer J Shin
Journal:  Curr Allergy Asthma Rep       Date:  2019-09-05       Impact factor: 4.806

5.  Actual therapeutic management of allergic and hyperreactive nasal disorders.

Authors:  Claudia Rudack
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28

6.  Comparison of Sinus Deposition from an Aqueous Nasal Spray and Pressurised MDI in a Post-Endoscopic Sinus Surgery Nasal Replica.

Authors:  Joey Siu; James van Strien; Rosa Campbell; Paul Roberts; Malcolm Drummond Tingle; Kiao Inthavong; Richard George Douglas
Journal:  Pharm Res       Date:  2022-02-08       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.